NPs Basic Information

Name
Luteolin
Molecular Formula C15H10O6
IUPAC Name*
2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
SMILES
C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O
InChI
InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H
InChIKey
IQPNAANSBPBGFQ-UHFFFAOYSA-N
Synonyms
luteolin; 491-70-3; Digitoflavone; Luteolol; 3',4',5,7-Tetrahydroxyflavone; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Flacitran; Luteoline; Salifazide; Weld Lake; Yama kariyasu; Cyanidenon 1470; Bismite; 5,7,3',4'-Tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; C.I. Natural Yellow 2; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; Daphneflavonol; Flavopurpol; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Cyanidenon-1470; BRN 0292084; MFCD00017309; KUX1ZNC9J2; CHEMBL151; FLAVONE, 3',4',5,7-TETRAHYDROXY-; CHEBI:15864; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; 1318-21-4; SMR000326896; 7-Tetrahydroxyflavone; CCRIS 3790; SR-01000779333; EINECS 207-741-0; UNII-KUX1ZNC9J2; Argemexitin; C.I. 75590; 4dew; 4dgn; 4hkn; Luteolin,(S); LU2; Prestwick_122; LUTEOLIN [INCI]; LUTEOLIN [MI]; Prestwick0_000870; Prestwick1_000870; Prestwick2_000870; Prestwick3_000870; LUTEOLIN [WHO-DD]; BIDD:PXR0059; Lopac0_000660; Oprea1_849964; SCHEMBL20426; BSPBio_000919; Luteolin, analytical standard; MLS000697655; MLS000860038; MLS002154043; MLS006011917; BIDD:ER0122; SPBio_002840; BDBM7459; BPBio1_001011; GTPL5215; MEGxp0_000143; DTXSID4074988; ACon1_000223; cid_5280445; HMS1570N21; HMS2097N21; HMS2220C06; HMS3356L02; HMS3561N09; HMS3649N21; HMS3656A05; HMS3714N21; Luteolin, >=99.0% (TLC); BCP03511; HY-N0162; TNP00073; Luteolin, >=98% (TLC), powder; BBL027837; LMPK12110006; s2320; STK801923; ZINC18185774; AKOS002140588; AC-1125; BCP9000865; CCG-208309; CS-4611; DB15584; KS-5202; Luteolin 100 microg/mL in Acetonitrile; SMP2_000042; NCGC00016467-01; NCGC00016467-02; NCGC00016467-03; NCGC00016467-04; NCGC00016467-05; NCGC00016467-06; NCGC00016467-07; NCGC00016467-08; NCGC00016467-21; NCGC00142375-01; NCGC00142375-02; NCGC00142375-03; NCGC00179375-01; NCGC00179375-02; CAS-491-70-3; SY030155; BCP0726000198; FT-0600053; SW196433-3; T2682; 91L703; C01514; L 9283; S00110; EN300-1659559; A827664; Luteolin, primary pharmaceutical reference standard; Q415011; Q-100551; SR-01000779333-4; SR-01000779333-5; SR-01000779333-7; BRD-K05236810-001-05-9; 23A002A4-B47B-46CD-848C-65042EACF3FF; NCGC00142375-01,NCGC00142375-02; Z1741977179; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-benzopyrone-4-one; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one #; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
CAS 491-70-3
PubChem CID 5280445
ChEMBL ID CHEMBL151
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Phenylpropanoids and poly
      • Class: Flavonoids
        • Subclass: Flavones
          • Direct Parent: Flavones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 286.24 ALogp: 1.4
HBD: 4 HBA: 6
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 107.0 Aromatic Rings: 3
Heavy Atoms: 21 QED Weighted: 0.512

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.028 MDCK Permeability: 0.00001000
Pgp-inhibitor: 0.004 Pgp-substrate: 0.274
Human Intestinal Absorption (HIA): 0.047 20% Bioavailability (F20%): 0.998
30% Bioavailability (F30%): 1

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.009 Plasma Protein Binding (PPB): 95.44%
Volume Distribution (VD): 0.533 Fu: 5.98%

ADMET: Metabolism

CYP1A2-inhibitor: 0.981 CYP1A2-substrate: 0.154
CYP2C19-inhibitor: 0.124 CYP2C19-substrate: 0.046
CYP2C9-inhibitor: 0.576 CYP2C9-substrate: 0.842
CYP2D6-inhibitor: 0.568 CYP2D6-substrate: 0.559
CYP3A4-inhibitor: 0.549 CYP3A4-substrate: 0.092

ADMET: Excretion

Clearance (CL): 8.146 Half-life (T1/2): 0.898

ADMET: Toxicity

hERG Blockers: 0.064 Human Hepatotoxicity (H-HT): 0.084
Drug-inuced Liver Injury (DILI): 0.905 AMES Toxicity: 0.536
Rat Oral Acute Toxicity: 0.046 Maximum Recommended Daily Dose: 0.741
Skin Sensitization: 0.946 Carcinogencity: 0.095
Eye Corrosion: 0.009 Eye Irritation: 0.944
Respiratory Toxicity: 0.22
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001533 0.701 D04AIT 1.000
ENC001529 0.686 D0K8KX 0.686
ENC001548 0.568 D06GCK 0.460
ENC001751 0.550 D07MGA 0.368
ENC004389 0.549 D0U3YB 0.341
ENC001573 0.545 D0TC7C 0.312
ENC001575 0.495 D0AZ8C 0.311
ENC005391 0.494 D08LFZ 0.289
ENC002024 0.493 D00KRE 0.283
ENC002018 0.493 D06KYN 0.281
*Note: the compound similarity was calculated by RDKIT.